Microplastics making you fat? probiotic pill shows promise in new study
NCT ID NCT07416214
First seen Jun 27, 2026 · Last updated Aug 18, 2026 · Updated 2 times
Summary
This study looked at whether tiny plastic particles (microplastics) we encounter daily might contribute to obesity and gut problems. Researchers gave 96 overweight or obese adults either a probiotic supplement or a placebo to see if the probiotic could reduce the harmful effects of microplastics. The goal was to find a simple nutritional way to help protect against weight gain and inflammation linked to plastic exposure.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
96 people
The number who actually took part.
- Started
-
Nov 2025
- Finished
-
Feb 2026
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 65 years
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Age 18-65 years. * Body Mass Index (BMI) ≥ 24.0 kg/m² or meeting the criteria for central obesity (waist circumference ≥ 90 cm for men, ≥ 85 cm for women); participants with mild abnormalities in blood lipids and liver function indicators will be prioritized. * Permanent residents of the local area during the trial period, with no plans for long-term business trips or travel. * Fully understand the research content and voluntarily sign the informed consent form. Exclusion Criteria: * Diagnosed congenital or acquired immunodeficiency diseases, severe allergic diseases, active gastrointestinal diseases, and other acute or chronic diseases requiring long-term treatment. * Use of antibiotics, immunosuppressants, probiotics, prebiotics, synbiotics, or other drugs that clearly affect gut microbiota or gastrointestinal function within the 6 months prior to the trial. * Regular intake of nutritional supplements (such as vitamins, fish oil, etc.) within the 6 months prior to the trial. * Having bad lifestyle habits such as smoking or alcoholism. * Women who are pregnant, lactating, or planning to become pregnant. * Weight change exceeding 5% of body weight within the 3 months prior to the trial. * Participation in or planning to participate in any other clinical intervention studies.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Inflammation are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
School of Public Health, Fudan University
Shanghai, Xuhui, 200030, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Which exercise dose best helps kids with metabolic syndrome?
- Custom knee guides put to the test in obese patients
- A pill for obesity? early human trial puts MDR-001 to the test
- Can a weekly shot help people who still struggle with weight after bariatric surgery?
- Can a berry extract help athletes bounce back after brutal workouts?
- Do GLP-1 Weight-Loss drugs change how teens eat and feel?